Showing results (171-180 of 186) with videos related to
Sort By:
Pageof 19
Genome Biology and Evolution|December 17, 2016
RAG Recombinase as a Selective Pressure for Genome EvolutionD Passagem-Santos, M Bonnet, D Sobral, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Dose-dense FEC followed by docetaxel versus docetaxel plus cyclophosphamide as adjuvant chemotherapy in women with HER2-negative, axillary lymph node-positive early breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)D Mavroudis, A Matikas, N Malamos, et al.Oncology|June 12, 2008
Modified CAPOX (capecitabine plus oxaliplatin) regimen every two weeks as second-line treatment in patients with advanced colorectal cancer previously treated with irinotecan-based frontline therapy: a multicenter phase II studyS Kakolyris, J Souglakos, A Polyzos, et al.Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|May 14, 2014
Conjugatable water-soluble Pt(II) and Pd(II) porphyrin complexes: novel nano- and molecular probes for optical oxygen tension measurement in tissue engineeringF Giuntini, V M Chauhan, J W Aylott, et al.Chemical Science|June 19, 2018
Direct imaging of changes in aerosol particle viscosity upon hydration and chemical agingN A Hosny, C Fitzgerald, A Vyšniauskas, et al.British Journal of Cancer|September 22, 2005
Second-line treatment with irinotecan plus cisplatin vs cisplatin of patients with advanced non-small-cell lung cancer pretreated with taxanes and gemcitabine: a multicenter randomised phase II studyV Georgoulias, A Agelidou, K Syrigos, et al.The Plant Cell|February 1, 1997
Cell cycle phase specificity of putative cyclin-dependent kinase variants in synchronized alfalfa cellsZ Magyar, T Mészáros, P Miskolczi, et al.Catheterization and Cardiovascular Diagnosis|July 24, 1998
Local and systemic delivery of low molecular weight heparin following PTCA: acute results and 6-month follow-up of the initial clinical experience with the porous balloon (PILOT-study). Preliminary Investigation of Local Therapy Using Porous PTCA BalloonsM Oberhoff, A Baumbach, T Hermann, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II studyG P Stathopoulos, K Syrigos, A Polyzos, et al.British Journal of Cancer|March 2, 2006
FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)J Souglakos, N Androulakis, K Syrigos, et al.Pageof 19